Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease.
In geriatric dogs, Alzheimer-like behavior is frequently observed. This behavior has been classified by several authors using questionnaires and a correlation has been described between cognitive dysfunctions and Alzheimer-like pathology. In the present study, cognitive performance was correlated with brain pathology for 30 dogs of varying ages. Within these animals, two age-matched groups of old dogs with and without behavioral changes were compared. The behavioral changes were analyzed and scored with questionnaires and necropsy was performed to rule out any other cause for changed behavior. Measurements, (immuno)-histochemical staining and fluorescence microscopy were used to detect cortex atrophy, amyloid, rest-products of oxidative damage, demyelination and accumulations of macrophages in the brains of these dogs. Spearman rank correlation coefficients (r) were calculated and adjusted according to Bonferonni. In the whole group (young to very old dogs), the age of the animal showed a significant correlation with various behavioral changes (r = 0.7 to 0.9, P < 0.01). The dementia score correlated significantly (r = 0.6 to 0.8, P < 0.01) with all the brain lesions studied, except one, i.e. demyelination (r = -0.4, P > 0.05). These results suggest that a questionnaire can be used to diagnose Alzheimer-like changes in canine practice. Oxidative damage on a cellular and a nuclear level plays an important role in behavior changes.
Rofina
J E
JE
Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3508 TD Utrecht, The Netherlands. J.Rofina@vet.uu.nl
van Ederen
A M
AM
Toussaint
M J M
MJ
Secrève
M
M
van der Spek
A
A
van der Meer
I
I
Van Eerdenburg
F J C M
FJ
Gruys
E
E
D000080242:8-Hydroxy-2'-Deoxyguanosine; D000367:Age Factors; D000375:Aging; D000447:Aldehydes / Q000378:metabolism; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology* / Q000662:veterinary*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001284:Atrophy / Q000378:metabolism / Q000473:pathology; D001522:Behavior, Animal; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology*; D003072:Cognition Disorders / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D003224:Congo Red; D003711:Demyelinating Diseases / Q000503:physiopathology / Q000662:veterinary; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000378:metabolism; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D007150:Immunohistochemistry / Q000379:methods; D008062:Lipofuscin / Q000378:metabolism; D008297:Male; D018709:Statistics, Nonparametric
D000447:Aldehydes; D016229:Amyloid beta-Peptides; D008062:Lipofuscin; D003224:Congo Red; D000080242:8-Hydroxy-2'-Deoxyguanosine; D003849:Deoxyguanosine; C027576:4-hydroxy-2-nonenal